Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

L Capital Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 14
Rounds per year 1.10
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.39
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Manufacturing
  • Medical
  • Therapeutics
Summary

The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the New York.

Among the most popular portfolio startups of the fund, we may highlight Intrapace, CeNeRx BioPharma, WiSpry. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Supply Chain Management, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the L Capital Partners, startups are often financed by Johnson & Johnson Development Corporation, Prism Venture Management, Oak Investment Partners. The meaningful sponsors for the fund in investment in the same round are Oak Investment Partners, Johnson & Johnson Development Corporation, HealthCap. In the next rounds fund is usually obtained by Quaker BioVentures, Oak Investment Partners, HealthCap.

The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this L Capital Partners works on 15 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2008. The higher amount of exits for fund were in 2015.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of L Capital Partners:
Typical Co-investors
L Capital Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after L Capital Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Borealis Canada, Magog, Ontario
Citrus Ventures California, Encino, United States
Danish Ministry of Environment and Food -
First Abu Dhabi Bank Dubai, United Arab Emirates
Hongli Zhihui Group China, Guangdong, Guangzhou
ITC Service Group California, Citrus Heights, United States
Just Business California, San Francisco, United States
Merced Capital Minnesota, Minnetonka, United States
Modern Times Group (MTG) Stockholm, Stockholm County, Sweden
NCSOFT Seoul, Seoul-t'ukpyolsi, South Korea
Nepenthe Capital -
New Market Education Partners Fulton, Maryland, United States
PE&HR Chiyoda, Japan
Rich Land Capital Beijing, Beijing, China
Ruisu Touzi China, Shanghai
Seed4Soft France, Ile-de-France, Paris
SoGal New York, New York, United States
VIC Partners -
Zhejiang Kente Touzi China, Ningbo, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biopharma
Biotechnology
Therapeutics
$13M13 Aug 2010 Cary, North Carolina, United States

WiSpry

Electronics
Infrastructure
Manufacturing
Mobile
Semiconductor
Wireless
$10M06 Apr 2009 Irvine, California, United States

Tengion

Biotechnology
Health Care
Medical
$21M19 Nov 2008 Lower Providence Township, Pennsylvania, United States

Evogen

Commercial
Government
Homeland Security
Information Technology
Manufacturing
Security
$3M17 Nov 2008 Kansas City, Missouri, United States

Biopharma
Biotechnology
Therapeutics
$15M29 Sep 2008 Cary, North Carolina, United States

Eleme Medical

Biotechnology
Health Care
Pharmaceutical
$18M16 Jul 2008 Merrimack, New Hampshire, United States

Exenta, Inc.

Enterprise Resource Planning (ERP)
Fashion
Manufacturing
Software
Supply Chain Management
$4M05 Jun 2008 New York, United States

WiSpry

Electronics
Infrastructure
Manufacturing
Mobile
Semiconductor
Wireless
$7M10 Mar 2008 Irvine, California, United States

Tengion

Biotechnology
Health Care
Medical
$33M15 Oct 2007 Lower Providence Township, Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent L Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 14M
Rounds per year 1.10
Peak activity year 2008
Lead investments 5
Follow on index 0.39
Exits 4
Group Appearance index 0.87

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Biopharma
Biotechnology
Therapeutics
$13M13 Aug 2010 Cary, North Carolina, United States

WiSpry

Electronics
Infrastructure
Manufacturing
Mobile
Semiconductor
Wireless
$10M06 Apr 2009 Irvine, California, United States

Tengion

Biotechnology
Health Care
Medical
$21M19 Nov 2008 Lower Providence Township, Pennsylvania, United States

Evogen

Commercial
Government
Homeland Security
Information Technology
Manufacturing
Security
$3M17 Nov 2008 Kansas City, Missouri, United States

Biopharma
Biotechnology
Therapeutics
$15M29 Sep 2008 Cary, North Carolina, United States

Eleme Medical

Biotechnology
Health Care
Pharmaceutical
$18M16 Jul 2008 Merrimack, New Hampshire, United States

Exenta, Inc.

Enterprise Resource Planning (ERP)
Fashion
Manufacturing
Software
Supply Chain Management
$4M05 Jun 2008 New York, United States

WiSpry

Electronics
Infrastructure
Manufacturing
Mobile
Semiconductor
Wireless
$7M10 Mar 2008 Irvine, California, United States

Tengion

Biotechnology
Health Care
Medical
$33M15 Oct 2007 Lower Providence Township, Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: